Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:08 PM
Ignite Modification Date: 2025-12-25 @ 2:08 PM
NCT ID: NCT04136366
Description: None
Frequency Threshold: 5
Time Frame: The safety assessment period was up to twenty-four weeks.
Study: NCT04136366
Study Brief: The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
ADX-2191 ADX-2191 (intravitreal methotrexate 0.8%) injected thirteen times over sixteen weeks 0 None 0 68 39 68 View
Standard Surgical Care Standard surgical care performed 0 None 1 38 24 38 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Punctate keratitis SYSTEMATIC_ASSESSMENT Eye disorders None View
Eye pain SYSTEMATIC_ASSESSMENT Eye disorders None View
Keratitis SYSTEMATIC_ASSESSMENT Eye disorders None View
Cystoid macular oedema SYSTEMATIC_ASSESSMENT Eye disorders None View
Eye irritation SYSTEMATIC_ASSESSMENT Eye disorders None View
Cataract SYSTEMATIC_ASSESSMENT Eye disorders None View
Cataract subcapsular SYSTEMATIC_ASSESSMENT Eye disorders None View
Conjunctival haemorrhage SYSTEMATIC_ASSESSMENT Eye disorders None View
Corneal oedema SYSTEMATIC_ASSESSMENT Eye disorders None View
Dry eye SYSTEMATIC_ASSESSMENT Eye disorders None View
Macular fibrosis SYSTEMATIC_ASSESSMENT Eye disorders None View
Vision blurred SYSTEMATIC_ASSESSMENT Eye disorders None View
Anterior chamber inflammation SYSTEMATIC_ASSESSMENT Eye disorders None View
Macular Oedema SYSTEMATIC_ASSESSMENT Eye disorders None View
Corneal epithelium defect SYSTEMATIC_ASSESSMENT Eye disorders None View
Anterior chamber cell SYSTEMATIC_ASSESSMENT Eye disorders None View
Hypotony of eye SYSTEMATIC_ASSESSMENT Eye disorders None View
Iris adhesions SYSTEMATIC_ASSESSMENT Eye disorders None View
Retinal haemorrhage SYSTEMATIC_ASSESSMENT Eye disorders None View
Anterior chamber fibrin SYSTEMATIC_ASSESSMENT Eye disorders None View
Eye pruritus SYSTEMATIC_ASSESSMENT Eye disorders None View
Posterior capsule opacification SYSTEMATIC_ASSESSMENT Eye disorders None View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Foreign body in eye SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications None View
Hyphaema SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications None View
Post procedural inflammation SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications None View
Intraocular pressure increased SYSTEMATIC_ASSESSMENT Investigations None View
Blood pressure increased SYSTEMATIC_ASSESSMENT Investigations None View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders None View